Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2017

Mar 2, 2017

30870_dirs_2017-03-02_f1f9698a-8ead-4ada-a57c-0c261a99575c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2017-02-28

Reporting Person: BARBARI SHARON SURREY (EVP, Finance & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-28 Common Stock A 18750 $0.0010 Acquired 47640 Direct
2017-02-28 Common Stock F 7317 $10.6 Disposed 40323 Direct